Healthcare is intensely personal, especially when devastating diagnoses arrive. Yet too often, a system weighed down by regulation and bureaucracy compounds that pain, forcing patients and families to navigate life-altering decisions without the support or flexibility they need.
In a recent piece published on The Capitalist Substack, Market Institute President Charles Sauer argues that this dynamic must change. Instead of funding systems and institutions, healthcare policy should focus on funding patients—giving them the power to make decisions that best suit their needs.
Shifting control away from government bureaucracies, insurance middlemen, and large hospital systems would allow Americans to direct resources toward the care that works for them. When patients control the dollars, the system begins to serve them rather than the other way around.
One of the clearest examples of why this patient-centered approach matters is Alzheimer’s disease.
Sauer points to a powerful story shared in The Wall Street Journal by Dr. Brent Beasley, who was diagnosed with Alzheimer’s at age 57 after losing his job due to unexplained cognitive issues. Despite being a physician with strong professional connections, it still took nearly a year to secure a definitive diagnosis—precious time when early intervention can make a life-changing difference.
Fortunately, Dr. Beasley’s story did not end in despair. Because his disease was detected early enough, his care team was able to intervene. Treatment helped him regain clarity, remain active in his church, and continue living a purposeful life. His experience demonstrates that an Alzheimer’s diagnosis no longer has to mean immediate decline.
Science is opening doors that did not exist a decade ago. But as Sauer notes, America’s healthcare system is still largely designed to react to crises rather than prevent them. Patients are often diagnosed too late, even though early interventions and lifestyle changes can have profound impacts.
Removing barriers to early testing, expanding access to innovative treatments, and supporting caregivers must become national priorities. The stakes are not only medical but economic. As analysts have warned, the growing number of Alzheimer’s cases could strain families, shrink the workforce, and place additional pressure on federal programs.
Other nations are already moving aggressively. China, for example, has launched a national Alzheimer’s initiative focused on awareness, screening, and early intervention. The United States must adopt a similar sense of urgency.
A serious strategy should include:
- Detecting the disease earlier
- Empowering primary care doctors
- Supporting innovation
- Reducing bureaucratic obstacles
- Putting patients back at the center of care
With the right policies, America can lead the world not just in extending lifespan, but in extending healthspan—allowing millions to remain active contributors to their families, communities, and the economy.
Behind every policy debate is a human story. As Sauer’s piece reminds us, the question is whether policymakers will act boldly enough to give families facing Alzheimer’s the tools and hope they deserve.
Read the full piece in The Capitalist by clicking here.
0 Comments